Cocoa Flavanols Cognitive Performance Randomized Trial: What the Evidence Says

Quick Answer

Cocoa Flavanols Cognitive Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Physical performance measures predict fall risk.Weak grip strength, slow walking speed, and other measures of poor physical performance have been associated with recurrent falls, hospitalization, and fractures.Given the personal and economic burden, safe and effective interventions are needed to prevent falls and maintain good physical function in older adults. [Chou Sharon H (2026); evidence level 2]
• The characteristics of dementia syndrome are cognitive dysfunction, including memory loss, reduced executive functions, language impairment, and affected performance in daily life activities. [Sbai Oualid (2026); evidence level 4]
• Notably, about 70% of older people are living in low-middle income countries, representing a significant economic weight associated with medical costs for health systems. [Sbai Oualid (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For cocoa flavanols cognitive performance randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Chou Sharon H (2026). Effects of cocoa extract supplementation on physical performance measures: results from the randomized controlled COcoa Supplement and Multivitamin Outcomes study. DOI: 10.1093/jbmrpl/ziag041. PMCID: PMC13089503. PMID: 42004609. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13089503/
• Sbai Oualid (2026). The Role of Polyphenols on Cognitive Function and Dementia Through Gut–Microbiota–Brain Axis Modulation: A Narrative Review. DOI: 10.3390/nu18111697. PMCID: PMC13259457. PMID: 42280341. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13259457/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.